Machine learning identifies potential diagnostic biomarkers associated with ferroptosis in obstructive sleep apnea
Authors:
Open Access
- 13 March 2025
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 29 (5) , 1-16
Abstract
Obstructive sleep apnea (OSA) is the most common sleep apnea‑related disorder, with a high prevalence and a range of associated complications. Ferroptosis is a new mode of cell death that is involved in the development of OSA, but the mechanism has remained elusive. In the present study, ferroptosis‑related genes in OSA were assessed and their potential clinical value was discussed. Data were downloaded and merged, and screened for differentially expressed genes (DEGs) through the Gene Expression Omnibus database. The OSA ferroptosis‑related genes were obtained after intersecting with the downloaded ferroptosis‑related genes. Subsequently, key ferroptosis‑associated differential genes were obtained using two machine learning methods (the least absolute shrinkage and selection operators and random forest). The immune infiltration in the samples and the correlation between key differential genes and immune infiltrating cells were then analyzed. A competing endogenous (ce)RNA visualization network was constructed to find possible therapeutic targets. Finally, the expression levels of key DEGs were verified by reverse transcription‑quantitative (RT‑q)PCR. In this study, 3 key ferroptosis‑related differential genes were identified: TXN, EGR1 and CDKN1A. Functional enrichment analysis showed that the three key differential genes in OSA can influence the development of OSA by affecting metabolism, immune response and other processes. RT‑qPCR experiments verified the expression of these key genes, further confirming the findings. A persistent state of immune activation may promote the progression of OSA, with marked infiltration of T cells and natural killer cells in OSA tissues. Genipin is a possible targeted therapeutic agent for OSA. Meanwhile, ceRNA network analysis identified several long non‑coding RNAs that can regulate OSA disease progression. A total of 3 key ferroptosis‑related markers were identified (TXN, EGR1 and CDKN1A) that are closely associated with metabolic disorders and immune responses, and which may be targets for early diagnosis and treatment of OSA.Keywords
This publication has 64 references indexed in Scilit:
- Increased Cellular Proliferation and Inflammatory Cytokines in Tonsils Derived From Children With Obstructive Sleep ApneaPediatric Research, 2009
- Clinical Guideline for the Evaluation, Management and Long-term Care of Obstructive Sleep Apnea in AdultsJournal of Clinical Sleep Medicine, 2009
- Reduced Sleep Duration or Quality: Relationships With Insulin Resistance and Type 2 DiabetesProgress in Cardiovascular Diseases, 2009
- Loss of p21CDKN1Aimpairs entry to quiescence and activates a DNA damage response in normal fibroblasts induced to quiescenceCell Cycle, 2009
- Plasma Thioredoxin, a Novel Oxidative Stress Marker, in Patients with Obstructive Sleep Apnea Before and After Nasal Continuous Positive Airway PressureAntioxidants & Redox Signaling, 2008
- ROS Signaling in Systemic and Cellular Responses to Chronic Intermittent HypoxiaAntioxidants & Redox Signaling, 2007
- Genipin-induced apoptosis in hepatoma cells is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of mitochondrial pathwayBiochemical Pharmacology, 2005
- Activated CD8+ T-lymphocytes in obstructive sleep apnoeaEuropean Respiratory Journal, 2005
- Influence of Weight and Sleep Apnea Status on Immunologic and Structural Features of the UvulaAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001